Clinical associations of serum Golgi apparatus antibodies in an immunology laboratory cohort.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0323767 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-3083 (Electronic) Linking ISSN: 03009475 NLM ISO Abbreviation: Scand J Immunol Subsets: MEDLINE
    • Publication Information:
      Publication: Oxford : Blackwell Scientific Publications
      Original Publication: Oslo, Universitetsforlaget.
    • Subject Terms:
      Antibodies, Antinuclear* ; Autoimmune Diseases*; Autoantibodies ; Cohort Studies ; Golgi Apparatus ; Humans ; Retrospective Studies
    • Abstract:
      Introduction: Anti-Golgi antibodies (AGAs) are rare antibodies that are found as distinct, polarised cytoplasmic staining on the HEp-2 substrate.
      Methods: We performed a review of patients that demonstrated this autoantibody in a large laboratory cohort in Australia. Over a 24-month period, all patients that had a sample submitted for routine antinuclear antibodies (ANAs) that had AGA staining were retrospectively identified. Medical records were perused to identify clinical associations.
      Results: There were 23 813 ANAs identified with 34 patients (0.14%) demonstrating AGA staining. AGAs were found in a variety of inflammatory disorders, malignancies and liver diseases. They did not associate with any other significant ANA, and in contrast with previous studies, we did not find any association with systemic autoimmune rheumatic diseases.
      Conclusions: Anti-Golgi antibodies are rare, non-specific and possibly a bystander phenomenon. Future studies are required to study the origin and longitudinal clinical associations of these autoantibodies.
      (© 2021 The Scandinavian Foundation for Immunology.)
    • References:
      Munro S. Q&A: What is the Golgi apparatus, and why are we asking? BMC Biol. 2011;9(1):63.
      Fritzler MJ, Etherington J, Sokoluk C, Kinsella TD, Valencia DW. Antibodies from patients with autoimmune disease react with a cytoplasmic antigen in the Golgi apparatus. J Immunol. 1984;132(6):2904-2908.
      Nozawa K, Fritzler MJ, von Mühlen CA, Chan EKL. Giantin is the major Golgi autoantigen in human anti-Golgi complex sera. Arthritis Res Ther. 2003;6(2):R95.
      Lee AYS, Ang EBH. A clinical overview of autoantibodies in general practice rheumatology. Br J Gen Pract. 2014;64(626):485-486.
      Damoiseaux J, von Mühlen CA, Garcia-De La Torre I, et al. International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Auto Immun Highlights. 2016;7(1):1.
      Chan EKL, Damoiseaux J, de Melo CW, et al. Report on the second International consensus on ana pattern (ICAP) workshop in dresden 2015. Lupus. 2016;25(8):797-804.
      Vermeersch P, Van den Bergh K, Blockmans D, Westhovens R, Bossuyt X. Anti-Golgi autoantibodies are not clinically associated with systemic autoimmune diseases. Ann Rheum Dis. 2011;70(1):234-235.
      Hong HS, Chung WH, Hung SI, Chen MJ, Lee SH, Yang LC. Clinical association of anti-golgi autoantibodies and their autoantigens. Scand J Immunol. 2004;59(1):79-87.
      Stinton LM, Eystathioy T, Selak S, Chan EKL, Fritzler MJ. Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin Immunol. 2004;110(1):30-44.
      Seelig HP, Schranz P, Schröter H, Wiemann C, Renz M. Macrogolgin-a new 376 kD Golgi complex outer membrane protein as target of antibodies in patients with rheumatic disease and HIV infections. J Autoimmun. 1994;7(1):67-91.
      Rodríguez JL, Gelpi C, Thomson TM, Real FJ, Fernández J. Anti-golgi complex autoantibodies in a patient with Sjögren syndrome and lymphoma. Clin Exp Immunol. 1982;49(3):579-586.
      Lodh M, Pradhan D, Sahoo M, Das S. Anti golgi antibodies and cryoglobulins. Indian J Allergy Asthma Immunol. 2012;26(1):16.
      Hong HS, Morshed SA, Tanaka S, Fujiwara T, Ikehara Y, Nishioka M. Anti-Golgi antibody in rheumatoid arthritis patients recognizes a novel antigen of 79 kDa (doublet) by western blot. Scand J Immunol. 1992;36(6):785-792.
      Lee AYS, Nissen MJ, Beroukas D, Ahern MJ, Barbara JA. Detectable anti-proteinase-3 antibodies precede clinical manifestations in a case of anti-neutrophil cytoplasmic antibody-associated vasculitis. Scand J Rheumatol. 2021;50(1):76-77.
      Gauderon A, Roux-Lombard P, Spoerl D. Antinuclear antibodies with a homogeneous and speckled immunofluorescence pattern are associated with lack of cancer while those with a nucleolar pattern with the presence of cancer. Front Med. 2020;7(165):165.
      Nisihara R, Machoski MCC, Neppel A, Maestri CA, Messias-Reason I, Skare TL. Anti-nuclear antibodies in patients with breast cancer. Clin Exp Immunol. 2018;193(2):178-182.
      Lee AYS, Chataway T, Colella AD, Gordon TP, Wang JJ. Quantitative mass spectrometric analysis of autoantibodies as a paradigm shift in autoimmune serology. Front Immunol. 2019;10:2845.
      Han H, He Y, Hu J, Lau R, Lee H, Ji C. Disrupted ER-to-Golgi trafficking underlies anti-HIV drugs and alcohol-induced cellular stress and hepatic injury. Hepatol Commun. 2017;1(2):122-139.
      Lee AYS. The value of a negative antinuclear antibody (ANA) test: an often forgotten result. Reumatol Clin. In press. https://doi.org/10.1016/j.reuma.2021.04.002.
    • Contributed Indexing:
      Keywords: antibodies; antinuclear antibodies; cytoplasm; golgi
    • Accession Number:
      0 (Antibodies, Antinuclear)
      0 (Autoantibodies)
    • Publication Date:
      Date Created: 20211223 Date Completed: 20220404 Latest Revision: 20220531
    • Publication Date:
      20250114
    • Accession Number:
      10.1111/sji.13133
    • Accession Number:
      34942025